课题基金 / 基金详情

CE-22-010 Linking Individuals Needing Care for Substance Use Disorders in Urban Emergency Departments to Peer coaches (LINCS UP)

CE-22-010 Linking Individuals Needing Care for Substance Use Disorders in Urban Emergency Departments to Peer coaches (LINCS UP)
CE-22-010 将城市急诊科需要药物使用障碍护理的个人与同伴教练联系起来 (LINCS UP)
批准号:
10705815
负责人:
Joseph Carpenter
金额:
$75.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-30 至 2025-09-29

项目摘要

项目成果

Joseph Carpenter的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY: Deaths from drug overdose have risen to record levels since the onset of the COVID- 19 pandemic, disproportionately impacting Black individuals and people experiencing homelessness.(2-6) Fewer than one-third of the 8.3 million individuals living with an illicit drug use disorder in 2019 reported receiving treatment.(7) Telemedicine services have increased access to care for many patients living with substance use disorders (SUD), but the long-term role of this treatment approach in SUD care is uncertain.(8- 11) Multifaceted strategies are needed to build recovery capital and link vulnerable individuals to recovery resources.(12) Emergency department (ED) visits are an opportunity to screen for SUDs, initiate treatment, and link to recovery resources.(13, 14) Observational studies have noted that consultation with a peer recovery coach (PRC) was well-received in EDs, with high rates of engagement and satisfaction.(15, 16) PRCs facilitate conversations allowing patients to express their ideal pathway to recovery, provide linkage to services across the social ecology,(17, 18) and follow up to support recovery, including re-linkage to resources as needed. Nonetheless, their role in ED screening and linkage to resources, including the potential role of telemedicine, has not been rigorously evaluated.(13) The objective of this prospective study is to develop a robust evidence base supporting a novel approach to embedding peer recovery coaches in the ED setting to link patients with an illicit SUD to recovery support services. Investigators will conduct a Hybrid Type 1 effectiveness- implementation trial at Grady Memorial Hospital, a large, urban level 1 trauma center that serves a socioeconomically vulnerable and racial minority population with a high rate of substance use.(25, 26) The implementation component will be guided by the EPIS framework,(28, 29) and the effectiveness component will include a randomized controlled trial enrolling 600 subjects across three arms: in-person peer coaching with linkage to recovery support services and callbacks, telemedicine-based peer coaching with linkage and callbacks, or usual care. The public health impact of ED PRCs will be measured across the dimensions of the RE-AIM framework.(27) This work builds established partnerships with Georgia Council on Substance Abuse and other local community organizations to implement ED PRCs while uniquely integrating and evaluating their utility. Results will inform other EDs considering a peer recovery coach program for patients presenting with SUD-related conditions. By utilizing telemedicine, this model will be rapidly scalable and readily implemented at other facilities. This study’s focus directly aligns with the CDC’s funding priority to support interdisciplinary teams implementing evidence-based scalable approaches for linking individuals from communities experiencing a disproportionate burden of illicit substance use and overdose, such as the racially, ethnically, and economically diverse patient population seen in the Grady ED.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Linking Individuals Needing Care for Substance Use Disorders in Urban Emergency Departments to Peer coaches (LINCS UP)
  • 批准号:
    10592004
  • 项目类别:
  • 资助金额:
    $75.0万
  • 财政年份:
    2022
  • 负责人:
    Joseph Carpenter
  • 依托单位:
国内基金
海外基金
基于 ANKRD22 介导的脂代谢重编程激活Notch4/HES1 通路促进巨噬细胞获得免疫抑制表型机制研究
  • 批准号:
    ZCLMS26H1601
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    肖于飞
  • 依托单位:
基于“Akkermansia muciniphila—ILC3/IL-22轴”探究竹节参总皂苷改善高脂饮食诱导的脂质代谢紊乱
  • 批准号:
    JCZRLH202600409
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
SLC22A4作为冠心病新型炎症标志物的功能与机制研究
  • 批准号:
    2026JJ81785
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    刘斌
  • 依托单位:
miR-22通过调控巨噬细胞功能抑制免疫力的分子机制研究
  • 批准号:
    2026JJ81780
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    邢佼涛
  • 依托单位: